Bemarituzumab [CAS 1952272-74-0]
Partner: MedChemexpress LLC
| CAS No: | 1952272-74-0 |
| Applications: | Cancer-Kinase/protease |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Bemarituzumab] |
| Purity: | 99.50 |
| Description: | Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
